123 related articles for article (PubMed ID: 38331250)
1. Correlation between pre-radical prostatectomy standardized SUVmax ratios detected on 68Ga-PSMA-I&T PET/CT and final histopathology outcomes: an in-depth analysis.
Arıkan MG; Soyluoğlu S; Korkmaz Ü; Taştekin E; Elboğa U; Arda E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(2):100-106. PubMed ID: 38331250
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values.
Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D
Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016
[TBL] [Abstract][Full Text] [Related]
3. Predictive significance of intraprostatic volumetric parameters derived from early and standard time 68Ga-PSMA PET/CT images in newly diagnosed prostate cancer patients.
Erdogan EB; Tekce E; Koca S; Aslan N; Toluk O; Aydin M
Nucl Med Commun; 2024 Jul; 45(7):629-641. PubMed ID: 38835183
[TBL] [Abstract][Full Text] [Related]
4. [
Li B; Ding X; Duan L; Shi J; Tang M; Zhang J; Zhao Z; Wu X; Gao Y
Front Endocrinol (Lausanne); 2024; 15():1326858. PubMed ID: 38449842
[TBL] [Abstract][Full Text] [Related]
5.
von Klot CJ; Merseburger AS; Böker A; Schmuck S; Ross TL; Bengel FM; Kuczyk MA; Henkenberens C; Christiansen H; Wester HJ; Solass W; Lafos M; Derlin T
Nucl Med Mol Imaging; 2017 Dec; 51(4):314-322. PubMed ID: 29242725
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Ga-PSMA PET MRI with mpMRI in localization and regional staging of prostate cancer.
Deka H; Pooleri GK; Suguna B; Rajeshkannan R; Sekhar R; Bindhu MR; Prasad V
World J Urol; 2024 Mar; 42(1):153. PubMed ID: 38483621
[TBL] [Abstract][Full Text] [Related]
7. Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.
Mazzone E; Gandaglia G; Robesti D; Rajwa P; Gomez Rivas J; Ibáñez L; Soeterik TFW; Bianchi L; Afferi L; Kesch C; Darr C; Guo H; Zhuang J; Zattoni F; Fendler WP; Amparore D; Huebner NA; Giesen A; Joniau S; Schiavina R; Brunocilla E; Mattei A; Dal Moro F; Moreno Sierra J; Porpiglia F; Picchio M; Chiti A; van den Bergh R; Shariat SF; Montorsi F; Briganti A
Eur Urol Oncol; 2024 Apr; 7(2):231-240. PubMed ID: 37689506
[TBL] [Abstract][Full Text] [Related]
8. Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit.
Maestroni UV; Campobasso D; Guarino G; Acampora A; Scarlattei M; Ziglioli F; Dinale F; Baldari G; Migliari S; Gasparro D; Ferretti S; Silini EM; Ruffini L
Chin Clin Oncol; 2023 Jun; 12(3):22. PubMed ID: 37417288
[TBL] [Abstract][Full Text] [Related]
9.
Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.
Ucar T; Gunduz N; Demirci E; Culpan M; Gunel H; Kir G; Atis RG; Yildirim A
Prostate; 2022 Nov; 82(15):1462-1468. PubMed ID: 35915579
[TBL] [Abstract][Full Text] [Related]
11. Strong Correlation Between SUV
Berrens AC; Sorbi MA; Donswijk ML; de Barros HA; Azargoshasb S; van Oosterom MN; Rietbergen DDD; Bekers EM; van der Poel HG; van Leeuwen FWB; van Leeuwen PJ
J Nucl Med; 2024 Apr; 65(4):548-554. PubMed ID: 38485277
[TBL] [Abstract][Full Text] [Related]
12. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
13. Performance of Ga-68 PSMA PET/CT for diagnosis and grading of local prostate cancer.
Kwan TN; Spremo S; Teh AYM; McHarg D; Thangasamy I; Woo HH
Prostate Int; 2021 Jun; 9(2):107-112. PubMed ID: 34386454
[TBL] [Abstract][Full Text] [Related]
14. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates.
Rosenzweig B; Haramaty R; Davidson T; Lazarovich A; Shvero A; Haifler M; Gal J; Golan S; Shpitzer S; Hoffman A; Nativ O; Freifeld Y; Zreik R; Dotan ZA
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330410
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. The additional value of
Heetman JG; Paulino Pereira LJ; Kelder JC; Soeterik TFW; Wever L; Lavalaye J; van der Hoeven EJRJ; Lam MGEH; van Melick HHE; van den Bergh RCN
Prostate; 2024 May; ():. PubMed ID: 38704755
[TBL] [Abstract][Full Text] [Related]
17. 68Ga-PSMA PET/CT: Does it predict adverse pathology findings at radical prostatectomy?
Dekalo S; Kuten J; Mabjeesh NJ; Beri A; Even-Sapir E; Yossepowitch O
Urol Oncol; 2019 Sep; 37(9):574.e19-574.e24. PubMed ID: 31204017
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative
Qiu X; Chen M; Yin H; Zhang Q; Li H; Guo S; Fu Y; Zang S; Ai S; Wang F; Guo H
Front Oncol; 2021; 11():745530. PubMed ID: 34660310
[TBL] [Abstract][Full Text] [Related]
19. Tumor detection of
Tragardh E; Simoulis A; Bjartell A; Jogi J
J Nucl Med; 2021 Mar; 62(12):1735-40. PubMed ID: 33789930
[TBL] [Abstract][Full Text] [Related]
20. The role of PSMA PET/CT to predict upgrading in patients undergoing radical prostatectomy for ISUP grade group 1 prostate cancer.
Esen B; Seymen H; Gurses B; Armutlu A; Koseoglu E; Tarim K; Ertoy Baydar D; Sarikaya AF; Canda AE; Balbay D; Kordan Y; Tilki D; Esen T; Demirkol MO
Prostate; 2024 Jan; 84(1):32-38. PubMed ID: 37661579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]